Cargando…

Anti-Fibrotic and Anti-Angiogenic Activities of Osbeckia octandra Leaf Extracts in Thioacetamide-Induced Experimental Liver Cirrhosis

Chronic liver inflammation has become a major global health concern. In the absence of clinical surrogate markers to diagnose inflammatory liver disease, the intervention with effective drugs in modern medicine tends to be late. In Sri Lanka, traditional medical practitioners prescribe herbal prepar...

Descripción completa

Detalles Bibliográficos
Autores principales: Bogahawaththa, Sudarma, Kodithuwakku, Suranga P., Wijesundera, Kavindra K., Siriweera, Eranga H., Jayasinghe, Lalith, Dissanayaka, Waruna L., Rajapakse, Jayanthe, Herath, Chandana B., Tsujita, Tadayuki, Wijayagunawardane, Missaka P. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401385/
https://www.ncbi.nlm.nih.gov/pubmed/34443423
http://dx.doi.org/10.3390/molecules26164836
_version_ 1783745537795686400
author Bogahawaththa, Sudarma
Kodithuwakku, Suranga P.
Wijesundera, Kavindra K.
Siriweera, Eranga H.
Jayasinghe, Lalith
Dissanayaka, Waruna L.
Rajapakse, Jayanthe
Herath, Chandana B.
Tsujita, Tadayuki
Wijayagunawardane, Missaka P. B.
author_facet Bogahawaththa, Sudarma
Kodithuwakku, Suranga P.
Wijesundera, Kavindra K.
Siriweera, Eranga H.
Jayasinghe, Lalith
Dissanayaka, Waruna L.
Rajapakse, Jayanthe
Herath, Chandana B.
Tsujita, Tadayuki
Wijayagunawardane, Missaka P. B.
author_sort Bogahawaththa, Sudarma
collection PubMed
description Chronic liver inflammation has become a major global health concern. In the absence of clinical surrogate markers to diagnose inflammatory liver disease, the intervention with effective drugs in modern medicine tends to be late. In Sri Lanka, traditional medical practitioners prescribe herbal preparations from Osbeckia octandra for the prevention and treatment of liver disorders. To test the efficacy of such treatments, we have administered thioacetamide (TAA) to male Wistar rats to induce chronic liver damage (disease control; DC) and examined how various leaf extracts: crude leaf suspension (CLS), boiled leaf extract (BLE), sonicated leaf extract (SLE), methanol leaf extract (MLE) and hexane leaf extract (HLE) of O. octandra ameliorate TAA-induced liver disease. The CLS, BLE and SLE treatments in cirrhotic rats significantly attenuated disease-related changes, such as liver weight and hepato-enzymes. The mRNA levels of Tnf-α were significantly decreased by 3.6, 10 and 3.9 times in CLS, BLE and SLE compared to DC. The same treatments resulted in significantly lower (19.5, 4.2 and 2.4 times) α-Sma levels compared to DC. In addition, Tgf-β1 and Vegf-R2 mRNA expressions were significantly lower with the treatments. Moreover, BLE expressed a strong anti-angiogenic effect. We conclude that CLS, BLE and SLE from O. octandra have potent hepatic anti-fibrotic effects in TAA-induced liver cirrhosis.
format Online
Article
Text
id pubmed-8401385
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84013852021-08-29 Anti-Fibrotic and Anti-Angiogenic Activities of Osbeckia octandra Leaf Extracts in Thioacetamide-Induced Experimental Liver Cirrhosis Bogahawaththa, Sudarma Kodithuwakku, Suranga P. Wijesundera, Kavindra K. Siriweera, Eranga H. Jayasinghe, Lalith Dissanayaka, Waruna L. Rajapakse, Jayanthe Herath, Chandana B. Tsujita, Tadayuki Wijayagunawardane, Missaka P. B. Molecules Article Chronic liver inflammation has become a major global health concern. In the absence of clinical surrogate markers to diagnose inflammatory liver disease, the intervention with effective drugs in modern medicine tends to be late. In Sri Lanka, traditional medical practitioners prescribe herbal preparations from Osbeckia octandra for the prevention and treatment of liver disorders. To test the efficacy of such treatments, we have administered thioacetamide (TAA) to male Wistar rats to induce chronic liver damage (disease control; DC) and examined how various leaf extracts: crude leaf suspension (CLS), boiled leaf extract (BLE), sonicated leaf extract (SLE), methanol leaf extract (MLE) and hexane leaf extract (HLE) of O. octandra ameliorate TAA-induced liver disease. The CLS, BLE and SLE treatments in cirrhotic rats significantly attenuated disease-related changes, such as liver weight and hepato-enzymes. The mRNA levels of Tnf-α were significantly decreased by 3.6, 10 and 3.9 times in CLS, BLE and SLE compared to DC. The same treatments resulted in significantly lower (19.5, 4.2 and 2.4 times) α-Sma levels compared to DC. In addition, Tgf-β1 and Vegf-R2 mRNA expressions were significantly lower with the treatments. Moreover, BLE expressed a strong anti-angiogenic effect. We conclude that CLS, BLE and SLE from O. octandra have potent hepatic anti-fibrotic effects in TAA-induced liver cirrhosis. MDPI 2021-08-10 /pmc/articles/PMC8401385/ /pubmed/34443423 http://dx.doi.org/10.3390/molecules26164836 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Bogahawaththa, Sudarma
Kodithuwakku, Suranga P.
Wijesundera, Kavindra K.
Siriweera, Eranga H.
Jayasinghe, Lalith
Dissanayaka, Waruna L.
Rajapakse, Jayanthe
Herath, Chandana B.
Tsujita, Tadayuki
Wijayagunawardane, Missaka P. B.
Anti-Fibrotic and Anti-Angiogenic Activities of Osbeckia octandra Leaf Extracts in Thioacetamide-Induced Experimental Liver Cirrhosis
title Anti-Fibrotic and Anti-Angiogenic Activities of Osbeckia octandra Leaf Extracts in Thioacetamide-Induced Experimental Liver Cirrhosis
title_full Anti-Fibrotic and Anti-Angiogenic Activities of Osbeckia octandra Leaf Extracts in Thioacetamide-Induced Experimental Liver Cirrhosis
title_fullStr Anti-Fibrotic and Anti-Angiogenic Activities of Osbeckia octandra Leaf Extracts in Thioacetamide-Induced Experimental Liver Cirrhosis
title_full_unstemmed Anti-Fibrotic and Anti-Angiogenic Activities of Osbeckia octandra Leaf Extracts in Thioacetamide-Induced Experimental Liver Cirrhosis
title_short Anti-Fibrotic and Anti-Angiogenic Activities of Osbeckia octandra Leaf Extracts in Thioacetamide-Induced Experimental Liver Cirrhosis
title_sort anti-fibrotic and anti-angiogenic activities of osbeckia octandra leaf extracts in thioacetamide-induced experimental liver cirrhosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401385/
https://www.ncbi.nlm.nih.gov/pubmed/34443423
http://dx.doi.org/10.3390/molecules26164836
work_keys_str_mv AT bogahawaththasudarma antifibroticandantiangiogenicactivitiesofosbeckiaoctandraleafextractsinthioacetamideinducedexperimentallivercirrhosis
AT kodithuwakkusurangap antifibroticandantiangiogenicactivitiesofosbeckiaoctandraleafextractsinthioacetamideinducedexperimentallivercirrhosis
AT wijesunderakavindrak antifibroticandantiangiogenicactivitiesofosbeckiaoctandraleafextractsinthioacetamideinducedexperimentallivercirrhosis
AT siriweeraerangah antifibroticandantiangiogenicactivitiesofosbeckiaoctandraleafextractsinthioacetamideinducedexperimentallivercirrhosis
AT jayasinghelalith antifibroticandantiangiogenicactivitiesofosbeckiaoctandraleafextractsinthioacetamideinducedexperimentallivercirrhosis
AT dissanayakawarunal antifibroticandantiangiogenicactivitiesofosbeckiaoctandraleafextractsinthioacetamideinducedexperimentallivercirrhosis
AT rajapaksejayanthe antifibroticandantiangiogenicactivitiesofosbeckiaoctandraleafextractsinthioacetamideinducedexperimentallivercirrhosis
AT herathchandanab antifibroticandantiangiogenicactivitiesofosbeckiaoctandraleafextractsinthioacetamideinducedexperimentallivercirrhosis
AT tsujitatadayuki antifibroticandantiangiogenicactivitiesofosbeckiaoctandraleafextractsinthioacetamideinducedexperimentallivercirrhosis
AT wijayagunawardanemissakapb antifibroticandantiangiogenicactivitiesofosbeckiaoctandraleafextractsinthioacetamideinducedexperimentallivercirrhosis